Table 4.
Vitamin C Supplement | Non Users | <400 mg/day | 400–700 mg/day | ≥700 mg/day | Patrend | Pbheterogeneity |
---|---|---|---|---|---|---|
Men | ||||||
Cases | 284 | 203 | 96 | 73 | ||
Multivariate-adjusted HR (95% CI)c | 1.00 [ref] | 1.08 (0.62–1.87) | 1.13 (0.70–1.83) | 0.98 (0.60–1.62) | 0.90 | 0.57 |
Women | ||||||
Cases | 171 | 140 | 69 | 57 | ||
Multivariate-adjusted HR (95% CI)c | 1.00 [ref] | 0.86 (0.64–1.17) | 1.01 (0.71–1.45) | 0.99 (0.67–1.46) | 0.45 | 0.75 |
Pooled analysis | ||||||
Multivariate-adjusted HR (95% CI)c | 1.00 [ref] | 0.99 (0.72–1.37) | 1.13 (0.88–1.45) | 1.04 (0.81–1.35) | 0.68 | 0.82 |
Ptrend calculated using median value for each quintile
P- value for heterogeneity is calculated from the Q-statistic and is used to quantify differences between studies.
Adjused for age (years), sex, smoking status (never, past, current), total vitamin E intake (quartiles), body mass index (<23, 23-<25, 25-<30, ≥30), physical activity (low, average, high), educational level (<high school, high school, >high school), and total calories.